MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Meridian Bioscience EV - Enterprise Value 2011-2026 | VIVO
Annual EV - Enterprise Value Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.27 B | 815 M | 718 M | 487 M | 696 M | 614 M | 669 M | 664 M | 620 M | 809 M | 625 M | 557 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.27 B | 487 M | 712 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Agilent Technologies
A
|
45.8 B | $ 118.37 | -1.17 % | $ 36 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 20.14 | -2.04 % | $ 217 M |  China |
 |
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M |  Israel |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Medpace Holdings
MEDP
|
14 B | $ 525.26 | 1.3 % | $ 15.2 B | USA |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 22.07 | 25.61 % | $ 1.18 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
NeoGenomics
NEO
|
1.85 B | $ 8.14 | -6.22 % | $ 1.04 B | USA |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 9.26 | -1.7 % | $ 2.01 B | USA |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | USA |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
13.2 B | $ 28.88 | -0.65 % | $ 20 B |  Niderland |
 |
Co-Diagnostics
CODX
|
-1.92 M | $ 1.42 | - | $ 1.89 M | USA |
 |
Castle Biosciences
CSTL
|
665 M | $ 24.4 | -0.89 % | $ 678 M | USA |
 |
Senseonics Holdings
SENS
|
376 M | $ 6.78 | -1.81 % | $ 283 M | USA |
 |
Soleno Therapeutics
SLNO
|
2.13 B | $ 52.59 | 0.03 % | $ 2.67 B | USA |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
Neuronetics
STIM
|
168 M | $ 1.41 | 1.08 % | $ 93 M | USA |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 180.6 | 0.02 % | $ 8.95 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Thermo Fisher Scientific
TMO
|
186 B | $ 520.64 | -2.04 % | $ 196 B | USA |
 |
Danaher Corporation
DHR
|
145 B | $ 194.14 | -2.02 % | $ 138 B | USA |
 |
Interpace Biosciences
IDXG
|
16.3 M | $ 2.2 | - | $ 9.73 M | USA |
 |
Trinity Biotech plc
TRIB
|
133 M | $ 0.7 | -0.91 % | $ 61.9 M |  Irlanda |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Twist Bioscience Corporation
TWST
|
1.55 B | $ 56.1 | -2.65 % | $ 3.36 B | USA |
 |
Illumina
ILMN
|
15.3 B | $ 131.42 | -0.64 % | $ 20.9 B | USA |
 |
Fulgent Genetics
FLGT
|
502 M | $ 16.12 | -0.31 % | $ 487 M | USA |
 |
Guardant Health
GH
|
15.2 B | $ 84.82 | -0.05 % | $ 10.6 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
990 K | $ 2.84 | -3.24 % | $ 92.2 K | USA |
 |
Biomerica
BMRA
|
6.63 M | $ 2.21 | 4.5 % | $ 5.08 M | USA |
 |
ICON Public Limited Company
ICLR
|
26.4 B | $ 117.7 | 1.03 % | $ 9.71 B | Irlanda |
 |
Waters Corporation
WAT
|
21.6 B | $ 323.16 | -0.93 % | $ 19.2 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 267.93 | 0.45 % | $ 22.3 B | USA |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |
 |
Celcuity
CELC
|
5.57 B | $ 124.57 | 0.89 % | $ 5.82 B | USA |
 |
Myriad Genetics
MYGN
|
598 M | $ 5.13 | -1.25 % | $ 475 M | USA |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 83.18 | -0.91 % | $ 5.61 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 193.13 | 0.89 % | $ 21.4 B | USA |